Login / Signup

Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease.

Marina ChulkinaChristina RohmerSteven McAninchRonaldo Paolo PanganibanRomain VillégerAustin PortoleseJustin CiocirlanWenjing YangClaire CohenWalter KoltunJohn F ValentineYingzi CongGregory YochumEllen J BeswickIrina V Pinchuk
Published in: Journal of Crohn's & colitis (2024)
Our data suggest that activation of MK2 within fibroblasts contributes to the chronic inflammation induced fibrosis in CD and that targeting MK2 has potential for the development of novel therapeutic approaches for fibrosis in CD.
Keyphrases